2019
DOI: 10.1016/j.dsx.2019.03.027
|View full text |Cite
|
Sign up to set email alerts
|

Serum sTWEAK levels in chronic periodontitis and type 2 diabetes mellitus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
9
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(11 citation statements)
references
References 45 publications
0
9
0
Order By: Relevance
“…For example, an elevated level of serum proteinase 3 (PR3) was determined in latent autoimmune diabetes mellitus in adults (LADA) patients by Yu et al suggesting PR3 to be a potential biomarker for differentiating LADA and T2DM patients [25]. As Acharya et al reported that serum Soluble Tumor Necrosis Factor-like Weak inducer of apoptosis (sTWEAK) level was lower in chronic periodontitis (CP) with T2DM patients than both CP and healthy individuals, and showed significant association with glycemic levels, indicating its potential role in T2DM [26]. Another study by Huang et al reported that serum haptoglobin (Hp) levels were significantly Fig.…”
Section: Discussionmentioning
confidence: 99%
“…For example, an elevated level of serum proteinase 3 (PR3) was determined in latent autoimmune diabetes mellitus in adults (LADA) patients by Yu et al suggesting PR3 to be a potential biomarker for differentiating LADA and T2DM patients [25]. As Acharya et al reported that serum Soluble Tumor Necrosis Factor-like Weak inducer of apoptosis (sTWEAK) level was lower in chronic periodontitis (CP) with T2DM patients than both CP and healthy individuals, and showed significant association with glycemic levels, indicating its potential role in T2DM [26]. Another study by Huang et al reported that serum haptoglobin (Hp) levels were significantly Fig.…”
Section: Discussionmentioning
confidence: 99%
“…The second class of receptors has several ligands, TNFSF12 (or tumor necrosis factorlike weak inducer of apoptosis (TWEAK)). TNFSF12 is expressed by leukocytes and is degraded to a soluble form in response to inflammatory stimuli [4]. TNFSF12 activates the NF-κB, ERK1/2 and p38 pathways and regulates proliferation, migration, differentiation, apoptosis, angiogenesis, and inflammation [4].…”
Section: Introductionmentioning
confidence: 99%
“…The second class of receptors has several ligands, TNFSF12 (or tumor necrosis factor-like weak inducer of apoptosis (TWEAK)). TNFSF12 is expressed by leukocytes and is degraded to a soluble form in response to inflammatory stimuli [ 4 ]. TNFSF12 activates the NF-κB, ERK1/2, and p38 pathways and regulates proliferation, migration, differentiation, apoptosis, angiogenesis, and inflammation [ 4 ].…”
Section: Introductionmentioning
confidence: 99%
“…TNFSF12 is expressed by leukocytes and is degraded to a soluble form in response to inflammatory stimuli [ 4 ]. TNFSF12 activates the NF-κB, ERK1/2, and p38 pathways and regulates proliferation, migration, differentiation, apoptosis, angiogenesis, and inflammation [ 4 ]. The role of TNFSF12 in adipose tissue (AT) and obesity is controversial.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation